| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.425 | 15.200 | 20.882 | 19.018 | 15.236 | 14.469 | 14.594 | 12.374 | 16.333 | 16.491 |
| Total Income - EUR | 27.425 | 15.250 | 20.904 | 19.073 | 15.279 | 14.469 | 14.594 | 12.382 | 16.333 | 16.491 |
| Total Expenses - EUR | 26.309 | 27.716 | 21.316 | 19.036 | 14.755 | 13.766 | 13.923 | 12.162 | 16.691 | 14.855 |
| Gross Profit/Loss - EUR | 1.115 | -12.466 | -412 | 37 | 524 | 702 | 671 | 220 | -358 | 1.636 |
| Net Profit/Loss - EUR | 293 | -12.924 | -1.039 | -535 | 66 | 305 | 233 | -151 | -358 | 1.431 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biolab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 12.456 | 10.061 | 10.164 | 9.799 | 1.208 | 1.238 | 994 | 1.303 | 332 | 360 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.059 | 1.049 | 1.031 | 1.012 | 993 | 974 | 952 | 955 | 124 | 0 |
| Cash | 11.397 | 9.012 | 9.133 | 8.787 | 216 | 265 | 42 | 348 | 207 | 360 |
| Shareholders Funds | 9.915 | -3.110 | -4.096 | -4.556 | -4.402 | -4.014 | -3.692 | -3.854 | -4.200 | -2.746 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.542 | 13.170 | 14.260 | 14.355 | 5.610 | 5.253 | 4.685 | 5.157 | 4.532 | 3.106 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Biolab S.r.l.